Nikolaos Gatselis
Nikolaos Gatselis
Affiliazione sconosciuta
Email verificata su
Citata da
Citata da
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome
P Ducrotté, P Sawant, V Jayanthi
World journal of gastroenterology: WJG 18 (30), 4012, 2012
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of …
K Zachou, N Gatselis, G Papadamou, EI Rigopoulou, GN Dalekos
Journal of hepatology 55 (3), 636-646, 2011
Adipokines as mediators of endothelial function and atherosclerosis
G Ntaios, NK Gatselis, K Makaritsis, GN Dalekos
Atherosclerosis 227 (2), 216-221, 2013
Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview
GN Dalekos, K Zachou, C Liaskos, N Gatselis
European journal of internal medicine 13 (5), 293-303, 2002
autoimmune hepatitis–current management and challenges
K Zachou, P Muratori, GK Koukoulis, A Granito, N Gatselis, A Fabbri, ...
Alimentary pharmacology & therapeutics 38 (8), 887-913, 2013
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics
NK Gatselis, K Zachou, GK Koukoulis, GN Dalekos
World journal of gastroenterology: WJG 21 (1), 60, 2015
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ...
Hepatology 66 (5), 1444-1453, 2017
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment
O Nitzan, M Elias, B Chazan, R Raz, W Saliba
World journal of gastroenterology: WJG 19 (43), 7577, 2013
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ...
Journal of hepatology 64 (4), 800-806, 2016
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
GV Papatheodoridis, GN Dalekos, C Yurdaydin, M Buti, J Goulis, ...
Journal of hepatology 62 (2), 363-370, 2015
Anti‐cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2‐glycoprotein I cofactor or features of antiphospholipid syndrome
K Zachou, C Liaskos, DK Christodoulou, M Kardasi, G Papadamou, ...
European journal of clinical investigation 33 (2), 161-168, 2003
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?
NK Gatselis, K Zachou, P Papamichalis, GK Koukoulis, S Gabeta, ...
Digestive and Liver Disease 42 (11), 807-812, 2010
Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome
E Kapsalaki, N Gatselis, A Stefos, K Makaritsis, A Vassiou, I Fezoulidis, ...
International journal of infectious diseases 13 (5), 564-569, 2009
Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?
PJ Weathers, M Towler, A Hassanali, P Lutgen, PO Engeu
World journal of pharmacology 3 (4), 39, 2014
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases
K Zachou, C Liaskos, E Rigopoulou, S Gabeta, P Papamichalis, ...
Clinical Immunology 119 (2), 203-212, 2006
Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis
C Liaskos, E Rigopoulou, K Zachou, S Georgiadou, N Gatselis, ...
Journal of autoimmunity 24 (3), 251-260, 2005
A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis
K Zachou, NK Gatselis, P Arvaniti, S Gabeta, EI Rigopoulou, ...
Alimentary pharmacology & therapeutics 43 (10), 1035-1047, 2016
Clinical significance of organ‐and non‐organ‐specific autoantibodies on the response to anti‐viral treatment of patients with chronic hepatitis C
NK Gatselis, SP Georgiadou, GK Koukoulis, N Tassopoulos, K Zachou, ...
Alimentary pharmacology & therapeutics 24 (11‐12), 1563-1573, 2006
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease
NK Gatselis, G Ntaios, K Makaritsis, GN Dalekos
Clinical and experimental medicine 14 (2), 121-131, 2014
Intrafamilial spread of hepatitis B virus infection in Greece
EK Zervou, NK Gatselis, E Xanthi, K Ziciadis, SP Georgiadou, GN Dalekos
European journal of gastroenterology & hepatology 17 (9), 911-915, 2005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20